Q3 Earnings Estimate for Biotricity Issued By HC Wainwright

Biotricity, Inc. (NASDAQ:BTCY) – Equities research analysts at HC Wainwright issued their Q3 2025 earnings estimates for Biotricity in a research report issued on Monday, November 18th. HC Wainwright analyst K. Dede forecasts that the company will post earnings of ($0.11) per share for the quarter. HC Wainwright currently has a “Neutral” rating on the stock. The consensus estimate for Biotricity’s current full-year earnings is ($0.43) per share. HC Wainwright also issued estimates for Biotricity’s Q4 2025 earnings at ($0.11) EPS.

Biotricity (NASDAQ:BTCY) last issued its earnings results on Monday, August 19th. The company reported ($0.49) earnings per share (EPS) for the quarter. The firm had revenue of $3.20 million for the quarter.

Biotricity Stock Performance

NASDAQ:BTCY opened at $0.37 on Tuesday. The stock has a 50-day simple moving average of $0.34 and a 200 day simple moving average of $0.64. Biotricity has a one year low of $0.19 and a one year high of $1.67. The company has a market capitalization of $8.37 million, a price-to-earnings ratio of -0.28 and a beta of 1.22.

Institutional Investors Weigh In On Biotricity

An institutional investor recently bought a new position in Biotricity stock. AE Wealth Management LLC acquired a new position in Biotricity, Inc. (NASDAQ:BTCY) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned 0.45% of Biotricity at the end of the most recent reporting period. 3.89% of the stock is currently owned by institutional investors and hedge funds.

About Biotricity

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.